Advertisement

The Latest

An FDA panel today decided to allow Pfizer, Johnson & Johnson and Regeneron Pharmaceuticals to continue trials for painkillers that were linked to joint failure after clinical trials in 2010, according to a Bloomberg Businessweek report.

The FDA suspended plans to relaunch the cancer pain treatment drug Onsolis pending changes to manufacturing issues with the product, according to a Medcity New report.

With new procedures, varying payor reimbursements and rising implant costs to consider, running a profitable, orthopedic-driven ASC can often be a delicate balancing act of conflicting demands. Karen Cannizzaro, CASC, administrator at Physicians Day Surgery Center in Naples, Fla., provides…

Advertisement